CSIMarket
 



<< Back to Financial Strength by Company within Major Pharmaceutical Preparations Industry

Major Pharmaceutical Preparations Industry Financial Strength Information


Financial Strength Information & Trends  
 


Category:   Period:  

Major Pharmaceutical Preparations Industry 2 Q 1 Q 0 Q 4 Q 3 Q
  2024 2024 2024 2023 2023
Quick Ratio (TTM) 0.56 0.56 0.76 0.76 0.71
Quick Ratio Ranking # 27 # 26 # 18 # 22 # 23
Working Capital Ratio (TTM) 1.42 1.39 1.87 1.87 1.6
Working Capital Ratio Ranking # 42 # 44 # 17 # 32 # 36
Working Capital Per Revenue 0.23 0.22 0.37 0.35 0.3
Working Capital Per Revenue Ranking # 85 # 84 # 97 # 93 # 94
Leverage Ratio (TTM) 1.9 1.77 1.59 1.59 1.76
Leverage Ratio Ranking # 47 # 43 # 41 # 45 # 42
Total Debt to Equity (TTM) 1 0.93 0.64 0.64 0.89
Total Debt to Equity Ranking # 65 # 63 # 42 # 66 # 58
Interest Coverage (TTM) 15.53 10.5 10.08 10.07 11.18
Interest Coverage Ranking # 40 # 34 # 38 # 31 # 28
Debt Coverage (TTM) 0.25 0.21 0.26 0.26 0.27
Debt Coverage Ranking # 70 # 78 # 61 # 67 # 52


Quick Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the 2 Q 2024, Quick Ratio fell to 0.56 a new Major Pharmaceutical Preparations Industry low.



Within Healthcare sector 3 other industries have achieved higher Quick Ratio. Quick Ratio total ranking fell in contrast to the previous quarter from 26 to 27.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Quick Ratio Statistics as of 2 Q 2024
High Average Low
5.88 1.02 0.56
1. quarter 2016   2. quarter 2024

Quick Ratio Industry Ranking
Within: No.
Sector # 4
Overall # 27


Other Quick Ratios
Compare Industry's quick ratio to Push's or S&P Constituent list of Major Pharmaceutical Preparations Industry
Highest Ranking Quick Ratios Lowest Ranking Quick Ratios
Quick Ratios for PUSH's Competitors Definiton of Quick Ratio


Major Pharmaceutical Preparations Industry Working Capital Ratio Statistics as of 2 Q 2024
 



Working Capital Ratio Statistics as of 2 Q 2024
High Average Low
2.55 1.82 1.39
1. quarter 2016   1. quarter 2024



Working Capital Ratio Comment
On the trailing twelve months basis Current Liabilities decreased faster than Industry's Current Assets, this led to improvement in Industry's Working Capital Ratio to 1.42 in the 2 Q 2024, Working Capital Ratio remained below Major Pharmaceutical Preparations Industry average.



Within Healthcare sector 5 other industries have achieved higher Working Capital Ratio. Working Capital Ratio total ranking has improved to 42, from total ranking in previous quarter at 44.



Working Capital Ratio Industry Ranking
Within: No.
Sector # 6
Overall # 42

Other Working Capital Ratios
Highest Ranking Working Capital Ratios Lowest Ranking Working Capital Ratios
Compare Industry's Working Capital ratio to Push's or S&P Constituent list of Major Pharmaceutical Preparations Industry
Working Capital ratios for PUSH's Competitors Definiton of Working Capital Ratio

Major Pharmaceutical Preparations Industry Working Capital Per Revenue Statistics as of 2 Q 2024
 
Working Capital Per Revenue Comment
On the trailing twelve months basis Major Pharmaceutical Preparations Industry's Working Capital Per Revenue sequentially grew to 0.23 in the 2 Q 2024, below Industry average. Due to decline in revenue year on year by -1.92%.



Within Healthcare sector 2 other industries have achieved lower Working Capital Per Revenue. Working Capital Per Revenue total ranking fell in contrast to the preceding quarter from 84 to 85.




Working Capital Per Revenue Statistics as of 2 Q 2024
High Average Low
0.49 0.33 0.12
3. quarter 2014   1. quarter 2016


Working Capital Per Revenue Industry Ranking
Within: No.
Sector # 3
Overall # 85



Other Working Capital Per Revenue
Compare Industry's Working Capital Per Revenue to Push's or S&P Constituent list of Major Pharmaceutical Preparations Industry
Return On Assets for Major Pharmaceutical Preparations Industry Definiton of Working Capital Per Revenue



Major Pharmaceutical Preparations Industry Leverage Ratio Statistics as of 2 Q 2024
 


Leverage Ratio Statistics as of 2 Q 2024
High Average Low
1.97 1.43 -0.51
3. quarter 2021   1. quarter 2016



Leverage Ratio Comment
Despite repayements of liabilities of 1.57%, in 2 Q 2024, Liabilities to Equity ratio detoriated to 1.9, above Industry average.



Among other Industries in the Healthcare sector 4 other industries have achieved lower Leverage Ratio.



Leverage Ratio overall ranking has fallen relative to the prior quarter from 43 to 47.



Leverage Ratio Industry Ranking
Within: No.
Sector # 5
Overall # 47

Other Leverage Ratios
Compare Industry's Leverage ratio to Push's or S&P Bond Interest rates
Highest Ranking Leverage Ratios Lowest Ranking Leverage Ratios
Leverage Ratios for PUSH's Competitors What is Leverage Ratio?


Major Pharmaceutical Preparations Industry Total Debt to Equity Ratio Statistics as of 2 Q 2024
 
Debt to Equity Ratio Comment
Despite debt repayement of 2.02%, in 2 Q 2024 ,Total Debt to Equity detoriated to 1 in the 2 Q 2024, a new Industry high.



Within Healthcare sector 4 other industries have achieved lower Debt to Equity Ratio. Debt to Equity Ratio total ranking has contracted relative to the preceding quarter from 63 to 65.




Debt to Equity Ratio Statistics as of 2 Q 2024
High Average Low
1 0.3 0.04
2. quarter 2024   4. quarter 2020



Debt to Equity Industry Ranking
Within: No.
Sector # 5
Overall # 65

Other Debt to Equity Ratios
Highest Ranking Debt to Equity Ratios Lowest Ranking Debt to Equity Ratios
Compare Industry's Debt to Equity ratio to Push's or S&P Definiton of Debt to Equity Ratio

Major Pharmaceutical Preparations Industry Interest Coverage Ratio Statistics as of 2 Q 2024
 


Interest Coverage Ratio Statistics as of 2 Q 2024
High Average Low
96.99 22.38 1.52
4. quarter 2014   1. quarter 2016

Interest Coverage Ratio Comment
On the trailing twelve months basis Major Pharmaceutical Preparations Industry's ebitda grew by 8.65 % in 2 Q 2024 sequentially, while interest expenses decreased, this led to improvement in Industry's Interest Coverage Ratio to 15.53 , Interest Coverage Ratio remained below Major Pharmaceutical Preparations Industry average.



In the Healthcare sector only one Industry has achieved higher Interest Coverage Ratio. Interest Coverage overall ranking fell in contrast to the prior period from 34 to 40.



Interest Coverage Ratio Industry Ranking
Within: No.
Sector # 2
Overall # 40

Other Interest Coverage Ratios
Highest Ranking Interest Coverage Ratios Lowest Ranking Interest Coverage Ratios
Compare Industry's Interest Coverage ratio to Push's or S&P Definiton of Interest Coverage Ratio


Major Pharmaceutical Preparations Industry Debt Coverage Statistics as of 2 Q 2024
 
Debt Coverage Ratio Comment
On the trailing twelve months basis Major Pharmaceutical Preparations Industry's ebitda grew by 8.65 % in 2 Q 2024 sequentially, faster than total debt, this led to improvement in Industry's Debt Coverage Ratio to 0.25 , Debt Coverage Ratio remained below Major Pharmaceutical Preparations Industry average.



Looking into Healthcare sector only one Industry has accomplished higher Debt Coverage Ratio. Debt Coverage Ratio total ranking has improved to 70, from total ranking in previous quarter at 78.




Debt Coverage Statistics as of 2 Q 2024
High Average Low
6.01 1.97 0.21
4. quarter 2020   1. quarter 2016



Debt Coverage Industry Ranking
Within: No.
Sector # 2
Overall # 70

Other Debt Coverage Ratios
Highest Ranking Debt Coverage Ratios Lowest Ranking Debt Coverage Ratios
See also Major Pharmaceutical Preparations Industry's Margin Definiton of Debt Coverage Ratio

Date modified: 2024-09-08T22:12:52+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com